Showing 271 - 277 of 277
We refer to the framework developed by Ijiri and Simon (1977) and to the notion of independent submarkets (Sutton 1998) to provide a simple candidate explanation for the shape of the firm growth distribution based on a model of proportional growth at the level of both the introduction of new...
Persistent link: https://www.econbiz.de/10005549644
Persistent link: https://www.econbiz.de/10010560917
Persistent link: https://www.econbiz.de/10008281431
The prominent role played by patents within the pharmaceutical domain is unquestionable. In this paper, we focus on a relatively neglected implication of patents: the effect of patent-induced information disclosure on the dynamics of R&D and market competition. The study builds upon the...
Persistent link: https://www.econbiz.de/10004966691
This paper shows how specific technological and relational regimes have shaped the growth of the network of R&D collaborative agreements in pharmaceuticals in the 1990s. Our analysis reveals the existence of a complex set of regimes of firm growth within the network, providing additional...
Persistent link: https://www.econbiz.de/10005722698
After the systemic effects of bank defaults during the recent financial crisis, and despite a huge amount of literature over the last years to detect systemic risk, no standard methodologies have been set up until now. We aim to build a concise but comprehensive picture of the state of the art,...
Persistent link: https://www.econbiz.de/10010894924
This book focuses on how digital technologies and rapid developments in artificial intelligence are shaping a new generation of cyber-physical systems based on the convergence among robots, sensors, and 3D printing. The book tells a story based on data and indicators to compare the resilience to...
Persistent link: https://www.econbiz.de/10012627083